Internal Light Emission via Insertion Device for Volumetric Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing light, especially in the ultraviolet and visible ranges, are limited by the opacity of media, preventing light penetration and utilization within biological or opaque materials, which restricts volumetric applications and surface-based reactions.

Innovation Solution

A system comprising an insertion device with an electronics assembly unit, including an emitter and receiver, that generates light internally within a medium or subject using an initiation signal, allowing for the treatment of diseases or disorders by activating photoactivatable drugs and agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Volume of moving object

If light sources are used externally to illuminate media, then surface-based reactions can be achieved, but light penetration is blocked by opacity preventing volumetric treatments

Engineering Contradiction:
Improvevolumetric treatment capabilityVSAvoidlight opacity blocking
Core Design Contradiction:
Volume of moving objectVSObject-affected harmful factors

Solution Approach 1:

Instead of illuminating the medium from the outside, the patent inverts the approach by placing light sources inside the medium. Insertion devices with emitters are positioned within the target medium, enabling internal light generation that overcomes opacity barriers and achieves volumetric treatment throughout the entire medium rather than just at the surface.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The patent introduces insertion devices as intermediary carriers that deliver light sources into the medium. These devices act as mediators between the external control system and the internal treatment zone, enabling precise positioning and control of light emission within opaque media to achieve deep tissue or bulk material treatment.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Volume of moving object

If insertion devices with internal emitters are used, then volumetric light production is enabled, but device complexity increases

Engineering Contradiction:
Improvevolumetric light productionVSAvoidinsertion device structure
Core Design Contradiction:
Volume of moving objectVSDevice complexity

Solution Approach 1:

The patent divides the treatment system into modular insertion devices that can be independently controlled. Each insertion device contains its own emitter and can be positioned at specific locations within the medium, allowing segmented treatment of different regions. This modular approach manages complexity by breaking down the overall system into manageable, interchangeable units.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces complex mechanical light delivery systems with electronically controlled emitters. Instead of using mechanical mirrors, lenses, or moving parts to direct light, the system uses electronically controllable light sources that can be activated and deactivated remotely, simplifying the mechanical complexity while enabling precise volumetric control.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Quantity of substance

If photoactivatable drugs are activated externally, then surface reactions occur, but deep tissue activation is prevented by light absorption

Engineering Contradiction:
Improvephotoactivatable drug activationVSAvoidlight energy penetration
Core Design Contradiction:
Quantity of substanceVSUse of energy by moving object

Solution Approach 1:

The patent inverts the traditional approach of external light activation by placing emitters inside the target medium. This internal positioning allows light energy to be generated directly where photoactivatable drugs are needed, bypassing the light absorption problem that occurs with external illumination and enabling deep tissue or bulk activation of pharmaceutical agents.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The patent applies local quality by enabling selective activation of photoactivatable drugs at specific locations within the medium. Emitters can be positioned and controlled to activate drugs only in the desired treatment zones, providing spatially selective treatment that maximizes drug efficacy while minimizing off-target effects.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the production of light internally within opaque media, facilitating volumetric treatments and reactions, enhancing the efficacy of photoactivated therapies and chemical processes by overcoming the limitations of light penetration.

Implementation Method 1

an emitter configured to emit light of a predetermined type

Methodology Applied
Scientific EffectLight emission: Light Emitting Diode

Implementation Method 2

a source configured to produce an initiation signal penetrating at least a part of the medium or the human or animal subject

Methodology Applied
Scientific EffectElectromagnetic radiation penetration: Electromagnetic Induction

Data Source

PatentUS11077316B2Insertion devices and systems for production of emitted light internal to a medium and methods for their use
Publication Date: 2021.08.03 IMMUNOLIGHT LLC
  • US11077316B2 patent drawing
  • US11077316B2 patent drawing
  • US11077316B2 patent drawing

AI summary

A system and method for emitting a wavelength of energy internal to a medium or internal to a human or animal subject, and methods for using the system in the treatment of a condition, disorder, or disease. The system includes 1) a source configured to produce an initiation signal penetrating at least a part of the medium or the human or animal subject and 2) an insertion device having an electronics assembly unit. The assembly unit includes 1) an emitter configured to emit the wavelength of energy of a predetermined type to treat a disease or disorder in the human or animal subject or to produce a change in the medium and 2) a receiver that receives the signal.